Latest News and Press Releases
Want to stay updated on the latest news?
-
EFFINGHAM, Ill., April 03, 2026 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (Nasdaq: MSBI) announced today that it will issue its first quarter 2026 financial results after market close on...
-
WALTHAM, Mass., April 03, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for...
-
HONG KONG, April 03, 2026 (GLOBE NEWSWIRE) -- AIOS Tech Inc. (NASDAQ: AIOS) (the “Company”), today announced that, on April 1, 2026, the Company received a letter from the Listing Qualifications...
-
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 03, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that...
-
ABU DHABİ, United Arab Emirates, April 03, 2026 (GLOBE NEWSWIRE) -- FAR Labs, an AI native lab building infrastructure, AI as Service (AIaS) and physical AI systems powered by Dizzaract, announced...
-
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
-
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
-
CAMBRIDGE, Mass., April 03, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene...
-
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on April...
-
WALTHAM, Mass., April 03, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneering long-acting antibodies and...